A new study of 77,000 patients has shed light on the effectiveness of GLP-1s, a type of weight-loss drug. The study's findings suggest that these drugs may not work for everyone and may need to be taken indefinitely to maintain their effects. The specifics of the study's results are unclear, but they appear to have significant implications for the future of obesity treatment.